THURSDAY, Sept. 12, 2019 -- Women with pelvic pain should consider the possibility of endometriosis and discuss it with their doctor, an expert in gynecology says.
While pelvic pain can be a sign of many conditions, endometriosis is among the most common. It occurs when cells from the lining of the uterus grow into other areas of the body. The condition affects one in 10 women of reproductive age, according to the American College of Obstetricians and Gynecologists.
MONDAY, Oct. 7, 2019 -- Bacterial vaginosis is a common infection in women that's usually easily treated with antibiotics. But for those who develop recurrent infections, treatment options have been limited.
Now, Israeli researchers report they were able to put recurrent infections into remission in four out of five women who received a "vaginal microbiome transplant." The transplant consisted of healthy bacteria collected from the vaginal fluid of donors without the condition, the researchers explained.
THURSDAY, Aug. 15, 2019 -- Nearly half of U.S. patients don't tell their physicians about potentially life-threatening risks such as domestic violence, sexual assault, depression or thoughts of suicide, a new study finds.
"For physicians to achieve your best health, they need to know what you are struggling with," said study senior author Angela Fagerlin.
THURSDAY, Sept. 5, 2019 -- Struggling with post-traumatic stress disorder (PTSD) may make a woman more vulnerable to ovarian cancer, a new study suggests.
Researchers analyzed data from a national study of nearly 55,000 U.S. women and concluded that those who'd had six to seven symptoms of PTSD -- such as being easily startled by common noises or avoiding reminders of the traumatic experience -- at some point in their life had twice the risk of ovarian cancer compared to those who never had any PTSD symptoms.
WEDNESDAY, Aug. 21, 2019 -- Here's some bad news for older women during flu season: Aging reduces the stronger immune response that women typically have to vaccination, a new study finds.
"We need to consider tailoring vaccine formulations and dosages based on the sex of the vaccine recipient, as well as their age," said study senior author Sabra Klein. She is an associate professor in the department of molecular microbiology and immunology at Johns Hopkins Bloomberg School of Public Health in Baltimore.